Tablets & Capsules

TC1119

Issue link: https://www.e-digitaleditions.com/i/1182030

Contents of this Issue

Navigation

Page 57 of 113

56 November 2019 Tablets & Capsules BUFFERS Ammonia solution Avantor Bicarbonate, sodium or potassium salt Avantor Barrington Nutritionals Innophos, Inc. Jost Chemical Co. Natrium Products, Inc. Roquette America, Inc. SPI Pharma Calcium carbonate AIC Avantor Barrington Nutritionals Generichem HealthCaps, LLC Huber Engineered Materials Jost Chemical Co. Omya, Inc. SPI Pharma Dibasic sodium/potassium phosphate AIC Avantor Budenheim USA, Inc. Innophos, Inc. Jost Chemical Co. Diethanolamine Avantor High functionality Avantor Malic acid AIC Avantor Barrington Nutritionals Monobasic sodium/potassium phosphate AIC Avantor Budenheim USA, Inc. Innophos, Inc. Jost Chemical Co. Monoethanolamine Avantor Monosodium glutamate Avantor Phosphoric acid Avantor Budenheim USA, Inc. Innophos, Inc. Potassium or sodium citrate AIC Avantor Barrington Nutritionals Jost Chemical Co. Potassium or sodium hydroxide AIC Avantor Generichem PlusPharma, Inc. Sucrose Biddle Sawyer Corp. Biogrund US, Inc. PlusPharma, Inc. Zein Biddle Sawyer Corp. Flozein Products BINDERS continued Starch, pregelatinized Colorcon, Inc. DFE Pharma Roquette America, Inc. Stearic acid Acme-Hardesty AIC Barrington Nutritionals BASF Budenheim offers a comprehensive range of superior phosphate products ... covering liquid and solid dosage forms and a wide range of functionalities for pharmaceutical companies. All DI-CAFOS ® and TRI-CAFOS ® grades for direct compression offer several advantages which include excellent flow properties, high tablet hardness and high content uniformity which are essential for high speed tablet manufacturing. ... and extensive global services, in- cluding technical and regulatory support completes the offer to our customers and has made Budenheim a leading player in this segment. Our Tabletting Competence Center enables us to run trials under real production conditions, helps us to understand the require- ments of the market and to develop customized solutions for you. TRI - CAFOS ® Superior excipients meeting your formulation challenges DI - CAFOS ® Budenheim USA, Inc. | 855 Grandview Avenue Suite 120 | Columbus, Ohio 43215 Phone +1 (614) 345 2400 | pharma@budenheim.com | www.budenheim.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC1119